P27KIP1phosphorylation by PKB/Akt Leads to Poor Breast Cancer Prognosis

Breast Cancer Research - United Kingdom
doi 10.1186/bcr596
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

AKT/PKB Signaling Mechanisms in Cancer and Chemoresistance

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2005English

PI3K-PKB/Akt Pathway

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2012English

DHX32 Expression Is an Indicator of Poor Breast Cancer Prognosis

Oncology Letters
Cancer ResearchOncology
2016English

ECT2 Associated to PRICKLE1 Are Poor-Prognosis Markers in Triple-Negative Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

The Elevated Preoperative Platelet-To-Lymphocyte Ratio Predicts Poor Prognosis in Breast Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2014English

An Independent Poor-Prognosis Subtype of Breast Cancer Defined by a Distinct Tumor Immune Microenvironment

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2009English

Elevated miR-301a Expression Indicates a Poor Prognosis for Breast Cancer Patients

Scientific Reports
Multidisciplinary
2018English

AKT/PKB Signaling: Navigating the Network

Cell
BiochemistryGeneticsMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy